☆ 4.4 Review

A pregnant patient with ALK-positive non-small cell lung cancer treated with alectinib: A case report and review of the literature

ONCOLOGY LETTERS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world

Aria Shokoohi et al.

Summary: The evolution of diagnosis and treatment for advanced NSCLC, including targeted therapy and immune checkpoint inhibitors, has significantly improved overall survival. With the introduction of targeted therapy and immunotherapy, there was a notable increase in survival in each successive time cohort, reflecting advancements in treatment options.

CANCER MEDICINE (2022)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Immunotherapy for cancer treatment during pregnancy

Jessica S W Borgers et al.

LANCET ONCOLOGY (2021)

添加到收藏夹

Article Oncology

First Case Report of Pregnancy on Alectinib in a Woman With Metastatic ALK-Rearranged Lung Cancer: A Case Report

Giovanna Scarfone et al.

Summary: This case report presents a female patient with ALK-rearranged metastatic lung adenocarcinoma who became pregnant while receiving alectinib treatment. With the collaborative effort of a multidisciplinary team, the patient continued the study drug throughout pregnancy and delivered a healthy baby girl. Both maternal and fetal parameters remained normal during the pregnancy, and the baby showed no developmental anomalies during the first 20 months of life. After 32 months from diagnosis, the mother is doing well and in partial remission.

JOURNAL OF THORACIC ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Lung Adenocarcinoma during Pregnancy: 11-Year Follow-Up

Angel Acosta Rojas et al.

CASE REPORTS IN ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer

Jose M. Pacheco et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Alectinib: A Review in Advanced, ALK-Positive NSCLC

Julia Paik et al.

DRUGS (2018)

添加到收藏夹

Article Oncology

Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients

Jorine de Haan et al.

LANCET ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Makoto Nishio et al.

LUNG CANCER (2018)

添加到收藏夹

Article Medicine, Research & Experimental

A Case of a Pregnant Woman Diagnosed as Having ALK-rearranged Lung Adenocarcinoma

Moegi Komura et al.

IN VIVO (2018)

添加到收藏夹

Article Oncology

FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib

Erin Larkins et al.

CLINICAL CANCER RESEARCH (2016)

添加到收藏夹

Article Oncology

Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping

Ibiayi Dagogo-Jack et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

添加到收藏夹

Article Obstetrics & Gynecology

Management of cancer in pregnancy

Frederic Amant et al.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2015)

添加到收藏夹

Review Oncology

New Treatment Options for Lung Adenocarcinoma - in View of Molecular Background

Nora Bittner et al.

PATHOLOGY & ONCOLOGY RESEARCH (2014)

添加到收藏夹

Article Oncology

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F. A. Peccatori et al.

ANNALS OF ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Lung cancer and pregnancy

Nesrin Sariman et al.

LUNG CANCER (2013)

添加到收藏夹

Article Oncology

Lung cancer in pregnancy: Report of nine cases from an international collaborative study

S. Boussios et al.

LUNG CANCER (2013)

添加到收藏夹

Article

Cancro do pulmão durante a gravidez: um caso incomum

I. Neves et al.

Revista Portuguesa de Pneumologia (2013)

添加到收藏夹

Article Oncology

Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study

Frederic Amant et al.

LANCET ONCOLOGY (2012)

添加到收藏夹

Article Oncology

Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes

Kristel Van Calsteren et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Review Oncology

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy

Thomas R. Webb et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2009)

添加到收藏夹

Editorial Material Oncology

Lung cancer during pregnancy: An emerging issue

Nicholas Pavlidis

LUNG CANCER (2008)

添加到收藏夹

Review Oncology

Conflicting priorities in surgical intervention for cancer in pregnancy

Brendan J. Moran et al.

LANCET ONCOLOGY (2007)

添加到收藏夹

Review Oncology

Use of chemotherapy during human pregnancy

E Cardonick et al.

LANCET ONCOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.